Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb: Thermo Fisher, Neogen, Gencove, Mawi DNA Technologies

Thermo Fisher Scientific QuantStudio 7 Pro Dx Real-Time PCR System 384-Well Option

Thermo Fisher Scientific has launched a 384-well option for its Applied Biosystems QuantStudio 7 Pro Dx Real-Time PCR System. The company originally launched the instrument in the US last November with a 96-well block. With the new option, users can easily switch between 96-well and 384-well blocks in order to change the throughput of their assays as needed.

Neogen and Gencove InfiniSeek Cattle WGS and Genotyping Solution

Neogen and Gencove have launched InfiniSeek, a cattle whole-genome sequencing and genotyping solution. The assay simultaneously yields low-pass whole-genome sequencing and high-coverage genotyping at preselected loci in a single molecular reaction, providing information on genomic sequence, specific genetic traits, and parentage markers. It has been validated to show more than 99 percent concordance with deep WGS. Pricing was not disclosed.

Mawi DNA Technologies NextSwab

Mawi DNA Technologies has launched NextSwab, a plastic swab for high-efficiency nasal sample collection. The company released this product in response to the COVID-19 swab shortage. The swab head has two channels, separated by a septum, that retain the collected nasal material. This can then be released into transport medium with a gentle shake. The swab is compatible with many sample transport tubes and does not require any preparation for specimen collection. It fully releases its contents into the sample transport medium.

For more new products and services, please visit the New Products page on our website.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.